These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1689411)

  • 21. Myocardial flow and function after regional beta-blockade in exercising dogs.
    Mass H; Gwirtz PA
    Med Sci Sports Exerc; 1987 Oct; 19(5):443-50. PubMed ID: 2891014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
    Yorikane R; Kanda A; Kimura T; Satoh S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
    de Feyter PJ; Serruys PW; Suryapranata H
    Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of intravenous metoprolol.
    Bourdillon PD; Canepa-Anson R; Rickards AF
    Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial actions of bevantolol on subendocardial blood flow and contractile function in ischemic myocardium.
    Gross GJ; Buck JD; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1979; 1(1):139-47. PubMed ID: 94375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
    Hadfield SE; Slee SJ; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.
    Pouleur H; Van Mechelen H; Balasim H; Rousseau MF; Charlier AA
    J Cardiovasc Pharmacol; 1984; 6(4):720-6. PubMed ID: 6206332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
    Limas CJ; Limas C
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs.
    Noguchi K; Ojiri Y; Chibana T; Moromizato H; Sakanashi M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):732-7. PubMed ID: 1682484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ; Murthy VS; Hwang TF
    J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
    Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart.
    Vigholt Sørensen E; Nielsen-Kudsk F
    Eur J Pharmacol; 1986 Jun; 125(3):363-71. PubMed ID: 2874040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nipradilol, a new beta-adrenoceptor blocking agent with vasodilating properties, on transmural energy metabolism in the underperfused canine heart.
    Higuchi M; Asakawa T
    Jpn J Pharmacol; 1987 Jun; 44(2):145-53. PubMed ID: 2888916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in contractility fail to alter the size of the functional border zone in anesthetized dogs.
    Drake DH; McClanahan TB; Ning XH; Gerren RA; Dunham WR; Gallagher KP
    Circ Res; 1987 Aug; 61(2):166-80. PubMed ID: 3621483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    McCaffrey PM; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.